These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
634 related items for PubMed ID: 16488666
1. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers. Williams JH, Sirsi SR, Latta DR, Lutz GJ. Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666 [Abstract] [Full Text] [Related]
5. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD. Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091 [Abstract] [Full Text] [Related]
6. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y, Yagi M, Wada H, Matsuo M. Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [Abstract] [Full Text] [Related]
7. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O. Science; 2004 Dec 03; 306(5702):1796-9. PubMed ID: 15528407 [Abstract] [Full Text] [Related]
8. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, Partridge TA, Wilton SD. Nat Med; 2003 Aug 03; 9(8):1009-14. PubMed ID: 12847521 [Abstract] [Full Text] [Related]
9. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G. J Gene Med; 2004 Oct 03; 6(10):1149-58. PubMed ID: 15386737 [Abstract] [Full Text] [Related]
10. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A. J Gene Med; 2009 Mar 03; 11(3):257-66. PubMed ID: 19140108 [Abstract] [Full Text] [Related]
11. Induced dystrophin exon skipping in human muscle explants. McClorey G, Fall AM, Moulton HM, Iversen PL, Rasko JE, Ryan M, Fletcher S, Wilton SD. Neuromuscul Disord; 2006 Oct 03; 16(9-10):583-90. PubMed ID: 16919955 [Abstract] [Full Text] [Related]
12. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping. Mitrpant C, Fletcher S, Iversen PL, Wilton SD. J Gene Med; 2009 Jan 03; 11(1):46-56. PubMed ID: 19006096 [Abstract] [Full Text] [Related]
17. Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres. Baranov A, Glazkov P, Kiselev A, Ostapenko O, Mikhailov V, Ivaschenko T, Sabetsky V, Baranov V. Gene Ther; 1999 Aug 03; 6(8):1406-14. PubMed ID: 10467365 [Abstract] [Full Text] [Related]